OFFICE NO 201 MANGAL CITY PLOT NO A-1 SCHEME NO 54 PU-4 INDORE
Disclosure and Disclaimer Document
SEBI Registered Research Analyst
Registration No.: INH000019488
This Disclosure Document is prepared in accordance with SEBI (Research Analyst) Regulations, 2014. It provides essential information about research and recommendation services to assist clients in making informed decisions.
About the Research Entity
Disclosures
· Research Analyst or its employee or its associates have not received any compensation or other benefits from the Subject Company or 3rd party in connection with the research report/ recommendation.
· Research Analysts has not been engaged in market making activity of the subject company.
An IT firm or MSP who keeps your IT running smoothly at all times is like a plumber
who fixes your pipes; that’s what they are supposed to do.
Audit to examine alleged violations of SEBI Act, Securities Contracts, and the Companies Act
Read Details
Regulator outlines focus on disclosure quality, patient capital and deeper bond markets
Read Details
Total revenues increased 22 per cent to Rs 249 crore during the quarter.
Read Details
The issue is set to open for subscription on January 16 and run through January 30
Read Details
India's biggest bourse and the world's most active derivatives exchange has been trying to list since 2016
Read Details
The Trump administration has attacked India for months over purchases of oil that Washington says are supporting President Vladimir Putin’s war in Ukraine, and ultimately imposed punitive 50% tariffs
Read DetailsAt Fusiontech Research, we provide insightful, research-backed solutions to help traders grow with confidence and make informed investment decisions.